FREELINE THERAPEUTICS HLDGS shareholders Q3 2023

FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 1 filers reported holding FREELINE THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is - and the average weighting 9.3%.

FREELINE THERAPEUTICS HLDGS shareholders Q3 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 1,466,507$6,217,9909.26%
External links

This page lists FREELINE THERAPEUTICS HLDGS's shareholders in Q3 2023. To view FREELINE THERAPEUTICS HLDGS's shareholder history, click here.